Shima Moradi‐Kalbolandi

Author

Also Known As

S. Moradi-kalbolandi, Shima Moradi-Kalbolandi, Shima Moradi-kalbolandi, Shima Moradi‐Kalbolandi

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

Shima Moradi‐Kalbolandi is an author at Biotechnology Research Center specializing in immunology, immunotherapy, and medicine.

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	51
2	Cell Biology	2	2	20
3	Engineering	1	1	19
4	Natural Sciences	1	1	10
5	Biomedical Engineering	1	1	19

Shima Moradi‐Kalbolandi

Publications

Citations

H-Index

Page 1

	Year	Citations
Development of anti-CD47 single-chain Variable Fragment Targeted Magnetic Nanoparticles for Treatment of Human Bladder Cancer Gashin Rezaei, Mahdi Habibi‐Anbouhi, Morteza Mahmoudi, Nanomedicine	2017	19
Evaluation the potential of recombinant anti-CD3 nanobody on immunomodulatory function Shima Moradi‐Kalbolandi, Azadeh Sharifi-K, Behrad Darvishi, Molecular Immunology NanomedicineEngineeringNanobiotechnologyImmunologyImmunoediting	2019	19
Engineered hypoxia-responding Escherichia coli carrying cardiac peptide genes, suppresses tumor growth, angiogenesis and metastasis in vivo Mitra Samadi, Keivan Majidzadeh‐A, Malihe Salehi, Journal of Biological Engineering	2021	19
Development of a recombinant anti-VEGFR2-EPCAM bispecific antibody to improve antiangiogenic efficiency Khadijeh Barzaman, Mitra Samadi, Shima Moradi‐Kalbolandi, Experimental Cell Research Antiangiogenic EfficiencyAngiogenesisNovel TherapyImmunologyAntibody Screening	2021	12
Antigenic assessment of a recombinant human CD90 protein expressed in prokaryotic expression system Narges Yousefi-Rad, Mohammad Ali Shokrgozar, Mahdi Behdani, Protein Expression and Purification Molecular ImmunologyAutoimmune DiseaseMedicineNatural SciencesImmunology	2015	10
Development of a novel engineered antibody targeting human CD123 Shima Moradi‐Kalbolandi, Mahdi Habibi‐Anbouhi, Majid Golkar, Analytical Biochemistry MedicineImmunologyAntigen ProcessingAntibody EngineeringHuman Cd123	2016	10

Page 1